Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Ginsenoside Rd Improves Anticancer Drug-induced Disturbance in Murine Airway Ciliary Motility

KOUTA NORIYAMA, NOBUHISA TODO, SEIKOU NAKAMURA, NOBUYO TAMIYA, MASAKI SHIGETA, YUKI TODA, SHIGEKUNI HOSOGI and EISHI ASHIHARA
Anticancer Research January 2026, 46 (1) 181-194; DOI: https://doi.org/10.21873/anticanres.17933
KOUTA NORIYAMA
1Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kd23007{at}ms.kyoto-phu.ac.jp
NOBUHISA TODO
1Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SEIKOU NAKAMURA
2Laboratory of Pharmacognosy, Kyoto Pharmaceutical University, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NOBUYO TAMIYA
3Pulmonary Medicine, Rakuwakai Otowa Hospital, Kyoto, Japan;
4Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAKI SHIGETA
5Department of Anatomy and Developmental Biology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKI TODA
1Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIGEKUNI HOSOGI
1Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EISHI ASHIHARA
1Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ash{at}mb.kyoto-phu.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Lung cancer patients often suffer from chemotherapy-associated complications such as pneumonia and respiratory infections, which are caused by damage to normal cells and airway epithelial tissue. Mucociliary clearance (MCC) involves adsorption of foreign substances by mucus secreted by goblet cells, followed by propulsion into the airway by ciliated cells. MCC is a crucial mechanism that protects against infection. Previously, we demonstrated that ginsenoside Rd (Rd) activates MCC by increasing ciliary beat frequency (CBF). The aims of this study were to assess whether anticancer drugs decrease the CBF of murine airway ciliated cells, and to examine the effects of Rd on CBF suppression.

Materials and Methods: The CBF of primary epithelial cells isolated from B6.SJL-Ptprca Pepcb/BoyJ (B6.CD45.1) mice were measured in the presence of various anticancer drugs, either alone or in combination with Rd. Intracellular cAMP concentrations ([cAMP]i) were measured in A549 PinkFlamindo cells, and intracellular Ca2+ concentrations ([Ca2+]i) were evaluated in A549 cells stained with Fluo-4, in the presence/absence of anticancer drugs and Rd.

Results: Doxorubicin, cisplatin, pemetrexed, paclitaxel, and docetaxel decreased the CBF of murine airway ciliated cells; however, this effect was ameliorated by Rd. In addition, paclitaxel and docetaxel decreased [Ca2+]i. Rd improved anticancer drug-induced airway ciliary motility by increasing [cAMP]i.

Conclusion: Anticancer drugs suppress CBF, suggesting that treatment may cause airway infections. Anticancer drug-induced suppression of CBF was ameliorated by Rd, indicating that Rd may reduce the risk of pneumonia and respiratory infections in patients with lung cancer.

Keywords:
  • Ginsenoside Rd
  • anticancer drug
  • ciliary beat frequency
  • airway ciliated cells
  • respiratory infection
  • Received October 13, 2025.
  • Revision received October 28, 2025.
  • Accepted October 30, 2025.
  • Copyright © 2026 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
View Full Text

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 46 (1)
Anticancer Research
Vol. 46, Issue 1
January 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ginsenoside Rd Improves Anticancer Drug-induced Disturbance in Murine Airway Ciliary Motility
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Ginsenoside Rd Improves Anticancer Drug-induced Disturbance in Murine Airway Ciliary Motility
KOUTA NORIYAMA, NOBUHISA TODO, SEIKOU NAKAMURA, NOBUYO TAMIYA, MASAKI SHIGETA, YUKI TODA, SHIGEKUNI HOSOGI, EISHI ASHIHARA
Anticancer Research Jan 2026, 46 (1) 181-194; DOI: 10.21873/anticanres.17933

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Ginsenoside Rd Improves Anticancer Drug-induced Disturbance in Murine Airway Ciliary Motility
KOUTA NORIYAMA, NOBUHISA TODO, SEIKOU NAKAMURA, NOBUYO TAMIYA, MASAKI SHIGETA, YUKI TODA, SHIGEKUNI HOSOGI, EISHI ASHIHARA
Anticancer Research Jan 2026, 46 (1) 181-194; DOI: 10.21873/anticanres.17933
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Study on the Synthesis and Structure-activity Relationship of 3-Styrylflavones Possessing Variously Hydroxylated D-ring Moiety
  • Real-time Capacity Reactance-based Innovative Technology for Detecting Malignant Cells: An Experimental Implementation in Head and Neck Tumors
  • Biological Features of Gastric Cancer After Neoadjuvant Chemotherapy
Show more Experimental Studies

Keywords

  • Ginsenoside Rd
  • anticancer drug
  • ciliary beat frequency
  • airway ciliated cells
  • respiratory infection
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire